SLC6A4 and major depressive disorder: Besides, increases in proximal SLC6A4 promoter methylation predicted increases in threat-related amygdala reactivity over the same time window, which in turn predicted elevated levels of depressive symptoms another year later, but this time solely in individuals with a MDD family history.